SAVA logo

Cassava Sciences (SAVA)

Profile

Full Name

Cassava Sciences, Inc.

Ticker Symbol

SAVA

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

July 14, 2000

Indexes

Not included

Website

http://www.cassavasciences.com

Employees

30

Key Details

Price

$1.40(-2.10%)

Market cap

Last Dividend

$14.00

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$1.46(+37.07% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.40
SAVA price is $1.40

30-Day Relative Volume

0.38
SAVA 30-day relative volume is 0.38

Price Performance

Price Most recent change

-2.1%
SAVA price was down -2.1% on Apr 16, 2025

Price YTD change

-40.68%
SAVA price is down -40.68% since January 1st

Price 1-year change

-93.34%
SAVA price is down -93.34% year-on-year

Price 3-year change

-94.67%
SAVA price is down -94.67% over the past 3 years

Price Range

Price All-time high

$184.63
SAVA price is currently -99.24% below its historical high of $184.63

Price 3-year low

$1.15
SAVA price is currently +21.74% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$67.63M
SAVA market capitalization is $67.63 million

Market cap 3-year change

-93.56%
SAVA market capitalization is down -93.56% over the past 3 years

Market cap All-time high

$5.41B
SAVA market capitalization is currently -98.75% below its historical high of $5.41 billion

Market cap sector rank

42.52%
SAVA market capitalization is higher than 42.52% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+11.7%
SAVA shares outstanding is up +11.7% year-on-year

Shares Outstanding 3-Year Change

+20.68%
SAVA shares outstanding is up +20.68% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.64
SAVA beta is 0.64

200-day SMA

$13.82
SAVA price is currently -89.87% below its 200-day simple moving average

50-day SMA

$2.19
SAVA price is currently -36.04% below its 50-day simple moving average

RSI

35.18
SAVA 14-day relative strength index is 35.18

Volume

0.38
SAVA 30-day relative volume is 0.38

ATR

$0.15
SAVA average true range is $0.15

10-day Historical Volatility

93.31%
SAVA 10-day historical volatility is 93.31%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$14.00
SAVA last dividend was $14.00 per share, with an ex-dividend date of December 13, 2010

Next Dividend

-
SAVA next dividend has not yet been announced

Dividend per share

Dividend per share

-
SAVA annual dividend per share value is unknown

Dividend per share Sector Rank

-
SAVA annual dividend per share is unknown

Dividend per share 1-Year Change

-
SAVA annual dividend per share 1-year change is unknown

Dividend per share 3-Year Change

-
SAVA annual dividend per share 3-year change is unknown

Dividend yield

Dividend yield

-
SAVA annual dividend yield value is unknown

Dividend yield Sector Rank

-
SAVA annual dividend yield is unknown

Other

Payout ratio

-
SAVA annual payout ratio value is unknown

Dividends paid

-
SAVA annual dividends paid value is unknown

Free cash flow

-$117.03M
SAVA annual free cash flow is -$117.03 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
SAVA annual revenue value is unknown

Revenue Analysts estimate

-
SAVA annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
SAVA annual revenue 1-year change is unknown

Revenue Sector rank

-
SAVA annual revenue is unknown

EPS

EPS

-$1.46
SAVA annual earnings per share is -$1.46

EPS Analysts estimate

-$0.55
SAVA annual earnings per share is currently +165.45% higher than the consensus analysts' forecast

EPS 1-year change

+37.07%
SAVA annual earnings per share is up +37.07% year-on-year

EPS Sector rank

46.36%
SAVA annual earnings per share is higher than 46.36% of companies in Healthcare sector

Profit

Gross profit

-
SAVA annual gross profit value is unknown

Gross margin

-
SAVA annual gross profit margin value is unknown

Operating profit

-$142.28M
SAVA annual operating income is -$142.28 million

Operating margin

-
SAVA annual operating profit margin value is unknown

Net income

-$24.34M
SAVA annual net profit is -$24.34 million

Net margin

-
SAVA annual net profit margin value is unknown

Expenses

Total expenses

$142.28M
SAVA annual total expenses is $142.28 million

Operating expenses

$142.28M
SAVA annual total operating expenses is $142.28 million

Cost of goods sold

-
SAVA annual cost of goods sold value is unknown

Selling, general & administrative expenses

$71.81M
SAVA annual SGA is $71.81 million

Depreciation and amortization

$1.13M
SAVA annual depreciation & amortization is $1.13 million

Interest expense

-
SAVA annual interest expense value is unknown

Income tax

-
SAVA annual income tax value is unknown

EBIT & EBITDA

EBIT

-$142.28M
SAVA annual earnings before interest & taxes is -$142.28 million

EBITDA

-$141.15M
SAVA annual EBITDA is -$141.15 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$157.53M
SAVA annual total assets is $157.53 million

Non current assets

$21.00M
SAVA annual long term assets is $21.00 million

Current assets

$136.53M
SAVA annual total current assets is $136.53 million

Cash and cash equivalents

$128.57M
SAVA annual cash & cash equivalents is $128.57 million

Accounts receivable

-
SAVA annual accounts receivable value is unknown

Inventory

-
SAVA annual inventory value is unknown

Liabilities

Total liabilities

$11.83M
SAVA annual total liabilities is $11.83 million

Long term liabilities

$79.00K
SAVA annual total long term liabilities is $79.00 thousand

Current liabilities

$11.75M
SAVA annual total current liabilities is $11.75 million

Accounts payable

$7.65M
SAVA annual accounts payable is $7.65 million

Debt

Total debt

$0.00
SAVA annual total debt is $0.00

Total debt 1-year change

0%
SAVA {parameterFullLabel} has remained unchanged year-on-year

Long term debt

-
SAVA annual long term debt value is unknown

Short term debt

-
SAVA annual short term debt value is unknown

Equity & Capital

Shareholders equity

$145.70M
SAVA annual stockholders equity is $145.70 million

Book value

$145.70M
SAVA annual book value is $145.70 million

Retained earnings

-$405.11M
SAVA annual retained earnings is -$405.11 million

Working capital

$124.78M
SAVA annual working capital is $124.78 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$116.93M
SAVA annual cash flow from operations is -$116.93 million

Cash from operations 1-year change

-42.55%
SAVA annual cash flow from operations is down -42.55% year-on-year

Cash from investing

-$103.00K
SAVA annual cash flow from investing activities is -$103.00 thousand

Cash from investing 1-year change

+75.12%
SAVA annual cash flow from investing activities is up +75.12% year-on-year

Cash from financing

$124.47M
SAVA annual cash flow from financing activities is $124.47 million

Cash from financing 1-year change

+4762.11%
SAVA annual cash flow from financing activities is up +4762.11% year-on-year

CAPEX

CAPEX

-
SAVA annual capital expenditures value is unknown

CAPEX 1-year change

-
SAVA annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$117.03M
SAVA annual free cash flow is -$117.03 million

Free cash flow 1-year change

-41.96%
SAVA annual free cash flow is down -41.96% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
SAVA annual gross profit margin value is unknown

Operating margin

-
SAVA annual operating profit margin value is unknown

Net margin

-
SAVA annual net profit margin value is unknown

ROA & ROE

ROA

-15.45%
SAVA annual return on assets is -15.45%

ROE

-16.71%
SAVA annual return on equity is -16.71%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SAVA price to earnings ratio value is unknown

PE ratio Sector rank

-
SAVA price to earnings ratio is unknown

PB Ratio

PB ratio

0.46
SAVA price to book ratio is 0.46

PB ratio Sector rank

28.58%
SAVA price to book ratio is higher than 28.58% of companies in Healthcare sector

PS Ratio

PS ratio

-
SAVA price to sales ratio value is unknown

PS ratio Sector rank

-
SAVA price to sales ratio is unknown

Enterprise value

Enterprise value

-$60.94M
SAVA enterprise value is -$60.94 million

Enterprise value Sector rank

1.4%
SAVA enterprise value is higher than 1.4% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

0.43
SAVA EV/EBITDA is 0.43

EV/EBITDA Sector rank

71.57%
SAVA EV/EBITDA is higher than 71.57% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

11.62
SAVA annual current ratio is 11.62

Quick ratio

-
SAVA annual quick ratio value is unknown

Leverage

Debt to equity

0.00
SAVA annual debt to equity ratio is 0.00

Interest coverage ratio

-
SAVA annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
SAVA piotroski f-score value is unknown

Altman Z-Score

-
SAVA altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Mar 25, 25 HC Wainwright & Co.
Neutral
Mar 4, 25 HC Wainwright & Co.
Neutral
Nov 26, 24 HC Wainwright & Co.
Neutral
Nov 8, 24 HC Wainwright & Co.
Buy
Oct 8, 24 HC Wainwright & Co.
Buy
Aug 13, 24 HC Wainwright & Co.
Neutral
Aug 8, 24 Rodman & Renshaw
Buy
Jul 19, 24 HC Wainwright & Co.
Neutral
Jul 1, 24 Jones Trading
Hold
Jul 1, 24 HC Wainwright & Co.
Neutral

Institutional Ownership

Similar stocks

Alpha Cognition (ACOG)
CLSD logo
Clearside Biomedical (CLSD)
CRBU logo
Caribou Biosciences (CRBU)
ICCM logo
IceCure Medical Ltd (ICCM)
IMAB logo
I-Mab (IMAB)
ZYXI logo
Zynex (ZYXI)
MCRB logo
Seres Therapeutics (MCRB)
Sagimet Biosciences (SGMT)
VIGL logo
Vigil Neuroscience (VIGL)
  • What is the ticker symbol for Cassava Sciences?
  • Does Cassava Sciences pay dividends?
  • What sector is Cassava Sciences in?
  • What industry is Cassava Sciences in?
  • What country is Cassava Sciences based in?
  • When did Cassava Sciences go public?
  • Is Cassava Sciences in the S&P 500?
  • Is Cassava Sciences in the NASDAQ 100?
  • Is Cassava Sciences in the Dow Jones?
  • When was Cassava Sciences's last earnings report?
  • When does Cassava Sciences report earnings?
  • Should I buy Cassava Sciences stock now?

What is the ticker symbol for Cassava Sciences?

The ticker symbol for Cassava Sciences is NASDAQ:SAVA

Does Cassava Sciences pay dividends?

No, Cassava Sciences does not pay dividends

What sector is Cassava Sciences in?

Cassava Sciences is in the Healthcare sector

What industry is Cassava Sciences in?

Cassava Sciences is in the Biotechnology industry

What country is Cassava Sciences based in?

Cassava Sciences is headquartered in United States

When did Cassava Sciences go public?

Cassava Sciences's initial public offering (IPO) was on July 14, 2000

Is Cassava Sciences in the S&P 500?

No, Cassava Sciences is not included in the S&P 500 index

Is Cassava Sciences in the NASDAQ 100?

No, Cassava Sciences is not included in the NASDAQ 100 index

Is Cassava Sciences in the Dow Jones?

No, Cassava Sciences is not included in the Dow Jones index

When was Cassava Sciences's last earnings report?

Cassava Sciences's most recent earnings report was on Mar 3, 2025

When does Cassava Sciences report earnings?

The next expected earnings date for Cassava Sciences is May 9, 2025

Should I buy Cassava Sciences stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page